I submitted an article to Seeking Alpha yesterday, in favor of Biogen Idec, and the stock ran up substantially this morning before my article was released around 11 AM Pacific Time. I own some BIIB. I just want to say that the editorial turnaround time was within normal limits, and other articles have appeared elsewhere that are also positive on BIIB, during the last few days.
Biogen Idec Product Pipeline will Propel it Higher
Don't ignore the risks, even when the upside dominates: keep diversified!